ELAINE S TURNER

Allopathic & Osteopathic Physicians|Allergy & Immunology RICHMOND, VA NPI 1477526432

General Payments — all program years on this page

$2,022.32

  • Category: General Payments
  • Program years: PY2018–2021
  • Record count: 97
  • As of (CMS publication): 2026-01-23

Latest program year (PY2021): $419.17 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2021) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $407.6119
Education $11.561

By paying entity

Latest program year (PY2021) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $702.5341
2019 $841.8832
2020 $58.744
2021 $419.1720

Records — PY2021 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
802376818 GlaxoSmithKline, LLC. $16.38 11/01/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
802541713 GlaxoSmithKline, LLC. $13.44 03/30/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
802598631 GlaxoSmithKline, LLC. $12.94 08/25/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
803093139 GlaxoSmithKline, LLC. $14.12 05/24/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
813327247 Novartis Pharmaceuticals Corporation $17.96 06/16/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
813327251 Novartis Pharmaceuticals Corporation $21.61 07/21/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
813327255 Novartis Pharmaceuticals Corporation $16.50 08/23/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
820231453 CSL Behring $20.60 04/22/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
820562519 Pharming Healthcare, Inc. $16.16 08/04/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829721813 AstraZeneca Pharmaceuticals LP $11.56 07/26/2021 Education Undisputed 01/23/2026 View at CMS
830039547 AstraZeneca Pharmaceuticals LP $104.94 11/30/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832128937 kaleo, Inc. $19.84 07/07/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832128939 kaleo, Inc. $20.12 10/18/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832128941 kaleo, Inc. $20.41 12/08/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832539679 PFIZER INC. $12.59 06/30/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
835908237 Genentech USA, Inc. $15.11 05/10/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
835908239 Genentech USA, Inc. $19.77 10/06/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
839679269 Teva Pharmaceuticals USA, Inc. $11.78 08/17/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
843401489 GENZYME CORPORATION $16.97 09/01/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
843401503 GENZYME CORPORATION $16.37 10/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.